Altering	VBG	_
hormone	NN	_
signals	NNS	_
can	MD	CUE-1
change	VB	_
how	WRB	_
the	DT	_
body	NN	_
works	VBZ	_
and	CC	_
may	MD	CUE-2
lead	VB	_
to	IN	_
health	NN	_
problems	NNS	_
.	.	_

Some	DT	CUE-1
people	NNS	CUE-1
speculate	VB	_
that	IN	_
endocrine	NN	_
disrupting	VBG	_
compounds	NNS	_
may	MD	CUE-2
be	VB	_
linked	VBN	_
to	IN	_
many	JJ	CUE-3
health	NN	CUE-3
concerns	NNS	CUE-3
,	,	_
such	JJ	_
as	IN	_
cancer	NN	_
,	,	_
diabetes	NN	_
,	,	_
obesity	NN	_
,	,	_
learning	VBG	_
disabilities	NNS	_
and	CC	_
behavioural	JJ	_
problems	NNS	_
.	.	_

Solid	NNP	_
human	JJ	_
evidence	NN	_
linking	VBG	_
EDCs	NNS	_
with	IN	_
these	DT	_
kinds	NNS	_
of	IN	_
effects	NNS	_
is	VBZ	_
hard	JJ	_
to	TO	_
determine	VB	_
,	,	_
but	CC	_
their	PRP$	CUE-1
is	VBZ	CUE-1
increasing	VBG	CUE-1
evidence	NN	CUE-1
from	IN	_
the	DT	_
fields	NNS	_
of	IN	_
epidemiology	NN	_
,	,	_
toxicology	NN	_
,	,	_
environmental	JJ	_
health	NN	_
,	,	_
and	CC	_
environmental	JJ	_
science	NN	_
that	WDT	_
suggests	VBZ	CUE-2
there	EX	CUE-3
might	MD	CUE-3
be	VB	CUE-3
something	NN	CUE-3
to	IN	_
the	DT	_
claims	NNS	_
.	.	_

